Bronchoscopic Microwave Ablation of Lung Tissue

NCT05786625 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2026-02-02

No results posted yet for this study

Summary

The primary purpose of this study is to evaluate the safety and feasibility of the Creo Medical MicroBlate™ Flex AB1 instrument used with the AB1 electrosurgical system in patients undergoing bronchoscopic microwave ablation of peripheral lung nodules.

Conditions

Interventions

DEVICE

Ablation

Bronchoscopy and microwave ablation of lung nodule

Sponsors & Collaborators

  • Creo Medical Limited

    lead INDUSTRY

Principal Investigators

  • Pallav L Shah, MD · Royal Brompton and Harefield NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-04
Primary Completion
2025-11-26
Completion
2026-12-31

Countries

  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05786625 on ClinicalTrials.gov